alprazolam has been researched along with Memory Disorders in 4 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As part of a placebo-controlled trial of alprazolam-XR (extended release) administered in combination with cognitive-behavioral therapy in patients with panic disorder, a battery of tests was used to measure neuropsychologic function." | 9.09 | Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder. ( Auerbach, M; Gladsjo, JA; Hahn, T; Haze, A; Judd, LL; McKinney, R; Oliver, T; Rabin, A; Rapaport, MH, 2001) |
| "In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 9.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| " As part of a placebo-controlled trial of alprazolam-XR (extended release) administered in combination with cognitive-behavioral therapy in patients with panic disorder, a battery of tests was used to measure neuropsychologic function." | 5.09 | Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder. ( Auerbach, M; Gladsjo, JA; Hahn, T; Haze, A; Judd, LL; McKinney, R; Oliver, T; Rabin, A; Rapaport, MH, 2001) |
| "This study was designed to identify a dose of alprazolam that would reduce anxiety associated with oral surgery without causing accompanying memory impairment." | 5.08 | Amnestic and anxiolytic effects of alprazolam in oral surgery patients. ( Coldwell, SE; Getz, T; Milgrom, P; Ramsay, DS, 1997) |
| "In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 5.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| " The results have implications for evaluating the safety of the long-term use of BZ medications." | 1.27 | Chronic use of benzodiazepines and psychomotor and cognitive test performance. ( Geller, AM; Lucki, I; Rickels, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coldwell, SE | 1 |
| Milgrom, P | 1 |
| Getz, T | 1 |
| Ramsay, DS | 1 |
| Gladsjo, JA | 1 |
| Rapaport, MH | 1 |
| McKinney, R | 1 |
| Auerbach, M | 1 |
| Hahn, T | 1 |
| Rabin, A | 1 |
| Oliver, T | 1 |
| Haze, A | 1 |
| Judd, LL | 1 |
| Lucki, I | 1 |
| Rickels, K | 1 |
| Geller, AM | 1 |
| Noyes, R | 1 |
| DuPont, RL | 1 |
| Pecknold, JC | 1 |
| Rifkin, A | 1 |
| Rubin, RT | 1 |
| Swinson, RP | 1 |
| Ballenger, JC | 1 |
| Burrows, GD | 1 |
3 trials available for alprazolam and Memory Disorders
| Article | Year |
|---|---|
Amnestic and anxiolytic effects of alprazolam in oral surgery patients.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Dental Anxiety; D | 1997 |
Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Attention; Delayed-Action Preparations | 2001 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F | 1988 |
1 other study available for alprazolam and Memory Disorders
| Article | Year |
|---|---|
Chronic use of benzodiazepines and psychomotor and cognitive test performance.
Topics: Adult; Affect; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clorazepate Dipotassium; Cogn | 1986 |